AR and prostate cancer: Consistent with Skp2’s role as a downstream effector of androgen receptor in mediating proliferation in prostate cancer cells [21], its expression level in androgen-responsive LNCaP cells is substantially higher than in androgen-independent PC-3 and DU-145 cells.